PMPRB Revised Draft Guidelines: Ambiguity could further reduce availability of new medicines for Canadians

Innovative Medicines Canada’s (IMC) initial interpretation of the Patented Medicine Prices Review Board’s (PMPRB) revised draft Guidelines is that they will further reduce the availability of new medicines in Canada by exacerbating an already unpredictable regulatory environment.

NewsGuest UserNovember 7, 2022BIOOQuébecbiotechnology, drone technology, pmprb, Innovative Medicine Canada

The Canadian Cancer Society, CQDM, the Cole Foundation and Oncopole grant close to $8.5 million to four researchers in Quebec to support pediatric cancer research

The Canadian Cancer Society (CCS), CQDM, the Cole Foundation and Oncopole – pôle cancer du FRQS announced, today, grants of $8,485,132 to finance four research projects in Quebec, as part of the Pediatric Cancer Research Initiative.

ECOGENE-21: Drones to promote access to clinical research

ECOGENE-21, a non-profit clinical and academic research organisation dedicated to providing access to innovation for unmet health needs, including rare or severe diseases, successfully completed the first flight demonstrations of the drone delivery process for clinical trials at the Centre of Excellence on Drones (CED) in Alma on September 28.